Robyn Guymer

Q: What Schools Are Affiliated With Robyn Guymer

Robyn Guymer is affiliated with the following schools: University of Melbourne, University of Utah

Robyn Guymer's AcademicInfluence.com Rankings

Robyn Guymer

Philosophy

#8004

World Rank

#11302

Historical Rank

Logic

#5040

World Rank

#6398

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Robyn Guymer's Degrees

Masters Medicine University of Melbourne
PhD Medicine University of Melbourne

Why Is Robyn Guymer Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Professor Robyn Guymer was awarded an Elizabeth Blackburn Fellowship from the NHMRC, and works in ophthalmology at Melbourne University. Guymer is a senior retinal specialist within the Royal Victorian Eye and Ear Hospital, and is the deputy director, Centre for Eye Research Australia. She works in age-related macular degeneration as a clinician, academic, and researcher, and has used nano-lasers to treat Age-related Macular Degeneration.

(See a Problem?)

Robyn Guymer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants (2015) (1024)
Seven New Loci Associated with Age-Related Macular Degeneration (2013) (741)
A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy (1999) (436)
Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3. (2017) (394)
Automatic segmentation of nine retinal layer boundaries in OCT images of non-exudative AMD patients using deep learning and graph search. (2017) (392)
Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study. (2011) (378)
Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study. (2011) (375)
Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group. (2019) (287)
First-in-Human Trial of a Novel Suprachoroidal Retinal Prosthesis (2014) (273)
Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration (2011) (264)
Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. (2008) (227)
Perifoveal müller cell depletion in a case of macular telangiectasia type 2. (2010) (216)
Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis (2007) (215)
Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration: Data from an Observational Study. (2015) (208)
The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. (2004) (198)
Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration. (2014) (189)
Heritability of refractive error and ocular biometrics: the Genes in Myopia (GEM) twin study. (2006) (186)
Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen: FLUID Study 24-Month Results. (2019) (181)
Changes in Bruch’s membrane and related structures with age (1999) (171)
Identification of a Rare Coding Variant in Complement 3 Associated with Age-related Macular Degeneration (2013) (171)
Age-related macular degeneration (2006) (162)
Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. (2012) (155)
Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings. (2017) (146)
Reticular pseudodrusen: a risk factor for geographic atrophy in fellow eyes of individuals with unilateral choroidal neovascularization. (2014) (144)
Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degeneration. (2015) (140)
Evidence of association of APOE with age‐related macular degeneration ‐ a pooled analysis of 15 studies (2011) (130)
Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration. (2014) (127)
Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy. (2019) (126)
ANTI-VEGF TREATMENT IN NEOVASCULAR AGE–RELATED MACULAR DEGENERATION: A Treat-and-Extend Protocol Over 2 Years (2014) (125)
Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration: The LEAD Randomized Controlled Clinical Trial. (2019) (123)
Delay to treatment and visual outcomes in patients treated with anti-vascular endothelial growth factor for age-related macular degeneration. (2012) (122)
Visual function tests as potential biomarkers in age-related macular degeneration. (2011) (121)
Fat consumption and its association with age-related macular degeneration. (2009) (117)
Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration. (2008) (115)
Measuring rod and cone dynamics in age-related maculopathy. (2008) (113)
Apolipoprotein (APOE) gene is associated with progression of age‐related macular degeneration (AMD) (2006) (110)
Alcohol consumption and the risk of age-related macular degeneration: a systematic review and meta-analysis. (2008) (106)
Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. (2001) (105)
Intrasession test-retest variability of microperimetry in age-related macular degeneration. (2013) (104)
Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 4. (2019) (103)
EFFICIENT CAPTURE OF HIGH-QUALITY DATA ON OUTCOMES OF TREATMENT FOR MACULAR DISEASES: The Fight Retinal Blindness! Project (2014) (99)
Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial. (2019) (95)
Loss of cone function in age-related maculopathy. (2003) (95)
Animal models of retinal disease. (2011) (95)
Abdominal obesity and age-related macular degeneration. (2011) (94)
Correlation of Histologic Features with In Vivo Imaging of Reticular Pseudodrusen. (2016) (94)
Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. (2011) (93)
Cholesterol‐lowering medications reduce the risk of age‐related maculopathy progression (2001) (91)
Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial (2019) (90)
Gene-environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infection. (2008) (86)
Reticular Pseudodrusen and Their Association with Age-Related Macular Degeneration: The Melbourne Collaborative Cohort Study. (2016) (86)
THE PREVALENCE AND RISK FACTORS OF EPIRETINAL MEMBRANES: The Melbourne Collaborative Cohort Study (2013) (85)
Choroidal thickness profiles in retinitis pigmentosa (2013) (84)
The SECURE study: long-term safety of ranibizumab 0.5 mg in neovascular age-related macular degeneration. (2013) (84)
Drusen in patient-derived hiPSC-RPE models of macular dystrophies (2017) (82)
Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration. (2006) (81)
Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration. (2013) (81)
Proof of Concept, Randomized, Placebo-Controlled Study of the Effect of Simvastatin on the Course of Age-Related Macular Degeneration (2013) (77)
TWO YEAR OUTCOMES OF “TREAT AND EXTEND” INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (2018) (77)
Ellipsoid zone on optical coherence tomography: a review (2016) (76)
Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration. (2015) (75)
Low-luminance visual acuity and microperimetry in age-related macular degeneration. (2014) (74)
Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration. (2013) (74)
The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study (2016) (71)
Flicker perimetry losses in age-related macular degeneration. (2004) (71)
Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration. (2005) (71)
Advances in implantable bionic devices for blindness: a review (2016) (70)
Nanosecond‐laser application in intermediate AMD: 12‐month results of fundus appearance and macular function (2014) (68)
A rare functional haplotype of the P2RX4 and P2RX7 genes leads to loss of innate phagocytosis and confers increased risk of age‐related macular degeneration (2013) (68)
Relationship between retinal microstructures on optical coherence tomography and microperimetry in age-related macular degeneration. (2014) (68)
Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease"). (2003) (66)
Dietary patterns and their associations with age-related macular degeneration: the Melbourne collaborative cohort study. (2014) (64)
C-reactive protein levels and complement factor H polymorphism interaction in age-related macular degeneration and its progression. (2010) (64)
Red meat and chicken consumption and its association with age-related macular degeneration. (2008) (62)
Modifiable risk factors for age‐related macular degeneration (2006) (62)
Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration (2011) (62)
Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration. (2007) (62)
HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration? (2005) (62)
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials (2022) (60)
Relationship between clinical macular changes and retinal function in age-related macular degeneration. (2012) (59)
Laser treatment in subjects with high-risk clinical features of age-related macular degeneration. Posterior pole appearance and retinal function. (1997) (59)
Reticular Pseudodrusen in Intermediate Age-Related Macular Degeneration: Prevalence, Detection, Clinical, Environmental, and Genetic Associations. (2016) (57)
20/20--Alcohol and age-related macular degeneration: the Melbourne Collaborative Cohort Study. (2012) (56)
Variants in the APOE gene are associated with improved outcome after anti-VEGF treatment for neovascular AMD. (2011) (56)
THE PREVALENCE ESTIMATES OF MACULAR TELANGIECTASIA TYPE 2: The Melbourne Collaborative Cohort Study (2010) (56)
Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study. (2006) (56)
Physical Activity and Age-related Macular Degeneration: A Systematic Literature Review and Meta-analysis. (2017) (55)
Analysis of rare variants in the complement component 2 (C2) and factor B (BF) genes refine association for age-related macular degeneration (AMD). (2009) (54)
Impact of Cataract Surgery on Quality of Life in Patients with Early Age-Related Macular Degeneration (2007) (53)
Fundus autofluorescence characteristics of nascent geographic atrophy in age-related macular degeneration. (2015) (53)
The Treat-and-Extend Injection Regimen Versus Alternate Dosing Strategies in Age-related Macular Degeneration: A Systematic Review and Meta-analysis. (2018) (53)
Genetic pleiotropy between age-related macular degeneration and 16 complex diseases and traits (2017) (53)
The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration. (2014) (52)
Relationship between the second reflective band on optical coherence tomography and multifocal electroretinography in age-related macular degeneration. (2013) (51)
A tag-single nucleotide polymorphisms approach to the vascular endothelial growth factor-A gene in age-related macular degeneration. (2007) (51)
Development of a surgical procedure for implantation of a prototype suprachoroidal retinal prosthesis (2014) (50)
Unraveling a complex genetic disease: age-related macular degeneration. (2006) (50)
Refractive errors in twin studies. (2006) (49)
Low luminance deficit and night vision symptoms in intermediate age-related macular degeneration (2015) (49)
The Experience of Age-related Macular Degeneration (2004) (49)
IMPLICATION OF RECURRENT OR RETAINED FLUID ON OPTICAL COHERENCE TOMOGRAPHY FOR VISUAL ACUITY DURING ACTIVE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH A TREAT AND EXTEND PROTOCOL (2016) (48)
Scheduled versus Pro Re Nata Dosing in the VIEW Trials. (2015) (47)
Microperimetry of nascent geographic atrophy in age-related macular degeneration. (2014) (46)
Assessment of Retinotopic Rod Photoreceptor Function Using a Dark-Adapted Chromatic Perimeter in Intermediate Age-Related Macular Degeneration. (2016) (46)
Cardiovascular Adverse Effects of Phenylephrine Eyedrops: A Systematic Review and Meta-analysis. (2015) (46)
Facts on fats (2006) (46)
Association of the M55L and Q192R paraoxonase gene polymorphisms with age-related macular degeneration. (2004) (42)
Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohort. (2014) (42)
Visual Impairment as a Function of Visual Acuity in Both Eyes and Its Impact on Patient Reported Preferences (2013) (42)
Alzheimer's Disease and the Early Signs of Age-Related Macular Degeneration. (2016) (41)
Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular Degeneration. (2016) (41)
Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer’s disease (2016) (41)
Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration (2008) (41)
Role of flicker perimetry in predicting onset of late-stage age-related macular degeneration. (2012) (41)
Restorative retinal laser therapy: Present state and future directions. (2017) (40)
Iris colour, ethnic origin and progression of age‐related macular degeneration (2003) (39)
Impact of reticular pseudodrusen on microperimetry and multifocal electroretinography in intermediate age-related macular degeneration. (2015) (39)
Dietary -3 Fatty Acid and Fish Intake in the Primary Prevention of Age-Related Macular Degeneration (2008) (39)
Longitudinal Associations Between Microstructural Changes and Microperimetry in the Early Stages of Age-Related Macular Degeneration. (2016) (39)
Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (CFH) gene family (2018) (39)
Reticular pseudodrusen: current understanding (2019) (39)
Identification of urinary biomarkers for age-related macular degeneration. (2011) (38)
Developing the impact of Vision Impairment-Very Low Vision (IVI-VLV) questionnaire as part of the LoVADA protocol. (2014) (38)
Comparison between multifocal electroretinography and microperimetry in age-related macular degeneration. (2014) (38)
Development and validation of a deep‐learning algorithm for the detection of neovascular age‐related macular degeneration from colour fundus photographs (2019) (38)
Blood storage at 4°C—factors involved in DNA yield and quality (2006) (37)
New treatments in age‐related macular degeneration (2003) (37)
Anti-Vascular Endothelial Growth Factor Use and Atrophy in Neovascular Age-Related Macular Degeneration: Systematic Literature Review and Expert Opinion. (2019) (36)
Macular Atrophy in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial Comparing Ranibizumab and Aflibercept (RIVAL Study). (2019) (36)
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration (2016) (36)
Test-Retest Repeatability of Microperimetry at the Border of Deep Scotomas. (2015) (35)
Cytoarchitecture of choroidal capillary endothelial cells. (2004) (35)
Subthreshold Nanosecond Laser Intervention in Intermediate Age-Related Macular Degeneration: Study Design and Baseline Characteristics of the Laser in Early Stages of Age-Related Macular Degeneration Study (Report Number 1). (2017) (35)
Central retinal function as measured by the multifocal electroretinogram and flicker perimetry in early age-related macular degeneration. (2011) (35)
Cataract surgery in high‐risk age‐related macular degeneration: a randomized controlled trial (2009) (34)
Prospective audit of exudative age-related macular degeneration: 12-month outcomes in treatment-naive eyes. (2013) (34)
Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome. (2005) (34)
Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials (2020) (33)
Characteristics of progression of early Age-related macular degeneration: the Cardiovascular Health and Age-related maculopathy Study (2007) (33)
Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration (2015) (32)
ATP-induced photoreceptor death in a feline model of retinal degeneration. (2014) (32)
Apolipoprotein E gene associations in age-related macular degeneration: the Melbourne Collaborative Cohort Study. (2012) (32)
Prospective Longitudinal Evaluation of Nascent Geographic Atrophy in Age-Related Macular Degeneration. (2019) (32)
Geographic atrophy in age-related macular degeneration and TLR3. (2009) (31)
Age-Related Macular Degeneration and Mortality: A Systematic Review and Meta-Analysis (2017) (31)
Reticular pseudodrusen: A critical phenotype in age-related macular degeneration (2021) (31)
UROCANIC ACID AS AN IMMUNOSUPPRESSANT IN ALLOTRANSPLANTATION IN MICE (1993) (31)
Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration: CAM Report 5. (2020) (31)
Exposure to Chlamydia pneumoniae infection and age-related macular degeneration: the Blue Mountains Eye Study. (2007) (31)
New era for personalized medicine: the diagnosis and management of age‐related macular degeneration (2009) (30)
Loss of Function of P2X7 Receptor Scavenger Activity in Aging Mice: A Novel Model for Investigating the Early Pathogenesis of Age-Related Macular Degeneration. (2017) (30)
Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS) (2008) (29)
Quantitative Analysis of the Ellipsoid Zone Intensity in Phenotypic Variations of Intermediate Age-Related Macular Degeneration. (2017) (28)
Static and flicker perimetry in age-related macular degeneration. (2013) (28)
Non-mydriatic Digital Macular Photography: How Good is the Second Eye Photograph? (2009) (28)
Visual Function Decline Resulting from Geographic Atrophy: Results from the Chroma and Spectri Phase 3 Trials. (2020) (28)
Therapeutic targeting of the complement system in age‐related macular degeneration: a review (2012) (28)
A transcriptome-wide association study based on 27 tissues identifies 106 genes potentially relevant for disease pathology in age-related macular degeneration (2020) (28)
Structural OCT Signs Suggestive of Subclinical Nonexudative Macular Neovascularization in Eyes with Large Drusen. (2019) (27)
Association of Genetic Variants With Response to Anti–Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration (2018) (27)
Chlamydia pneumoniae and age‐related macular degeneration: a role in pathogenesis or merely a chance association? (2007) (26)
Multiallelic copy number variation in the complement component 4A (C4A) gene is associated with late-stage age-related macular degeneration (AMD) (2016) (26)
Developing an instrumental activities of daily living tool as part of the low vision assessment of daily activities protocol. (2014) (25)
Analysis of the Arg345Trp disease‐associated allele of the EFEMP1 gene in individuals with early onset drusen or familial age‐related macular degeneration (2002) (25)
Subretinal Drusenoid Deposits and the Loss of Rod Function in Intermediate Age-Related Macular Degeneration. (2018) (25)
Past physical activity and age-related macular degeneration: the Melbourne Collaborative Cohort Study (2016) (25)
Automatic Identification of Pathology-Distorted Retinal Layer Boundaries Using SD-OCT Imaging (2017) (25)
Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab. (2015) (25)
Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular Degeneration. (2019) (24)
Longitudinal Changes in Retinotopic Rod Function in Intermediate Age-Related Macular Degeneration. (2018) (23)
Analysis of the EFEMP1 gene in individuals and families with early onset drusen (2005) (23)
Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in Age-Related Macular Degeneration: A LEAD Study Report. (2019) (23)
Predictors of AMD treatment response. (2012) (23)
Heritability of macular thickness determined by optical coherence tomography. (2006) (23)
Benign intracranial hypertension in chronic myeloid leukemia. (1993) (22)
Second reflective band intensity in age-related macular degeneration. (2013) (22)
Drusen Detection and Quantification for Early Identification of Age Related Macular Degeneration using Color Fundus Imaging (2013) (22)
Methodology of the Cardiovascular Health and Age-Related Maculopathy (CHARM) Study (2004) (22)
Comprehensive Analysis of Copy Number Variation of Genes at Chromosome 1 and 10 Loci Associated with Late Age Related Macular Degeneration (2012) (21)
Age‐related macular degeneration (AMD): More than meets the eye. The role of multimodal imaging in today's management of AMD—A review (2020) (21)
Analysis of Fluid Volume and its Impact on Visual Acuity in the FLUID Study as Quantified with Deep Learning. (2020) (21)
Measurement of Retinal Sensitivity on Tablet Devices in Age-Related Macular Degeneration. (2015) (21)
Blood storage at 4 degrees C-factors involved in DNA yield and quality. (2006) (21)
Determining the Contribution of Retinotopic Discrimination to Localization Performance With a Suprachoroidal Retinal Prosthesis. (2017) (21)
Longitudinal Assessment of Rod Function in Intermediate Age-Related Macular Degeneration With and Without Reticular Pseudodrusen. (2019) (21)
Fluorescein angiographic abnormalities after prophylactic macular photocoagulation for high-risk age-related maculopathy. (1999) (21)
A comparison of corneal, pancreas, and skin grafts in mice. A study of the determinants of tissue immunogenicity. (1994) (21)
Influence of laser photocoagulation on choroidal capillary cytoarchitecture (2001) (21)
GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration (2016) (21)
Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital (2003) (21)
Role of lysophosphatidic acid in the retinal pigment epithelium and photoreceptors. (2018) (21)
The longitudinal impact of macular telangiectasia (MacTel) type 2 on vision-related quality of life. (2011) (19)
Ranibizumab treatment for neovascular age-related macular degeneration: from randomized trials to clinical practice (2009) (19)
Prophylactic laser treatment to fellow eyes of unilateral retinal pigment epithelial tears. (1997) (19)
An intergenic region between the tagSNP rs3793917 and rs11200638 in the HTRA1 gene indicates association with age-related macular degeneration. (2010) (19)
Living with Geographic Atrophy: An Ethnographic Study (2019) (19)
Can genetic associations change with age? CFH and age-related macular degeneration. (2012) (19)
Progress in the clinical development and utilization of vision prostheses: an update (2016) (19)
Artificial Intelligence Algorithms for Analysis of Geographic Atrophy: A Review and Evaluation (2020) (18)
Uptake, persistence, and performance of weekly home monitoring of visual field in a large cohort of patients with glaucoma. (2020) (18)
Temporal sensitivity deficits in patients with high-risk drusen. (1999) (18)
Retinal Changes in an ATP-Induced Model of Retinal Degeneration (2016) (18)
Disclosing disease mechanisms with a spatio-temporal summation paradigm (2006) (18)
Developing a Very Low Vision Orientation and Mobility Test Battery (O&M-VLV) (2016) (18)
Stimulation of a Suprachoroidal Retinal Prosthesis Drives Cortical Responses in a Feline Model of Retinal Degeneration. (2016) (18)
Systemic lipid dysregulation is a risk factor for macular neurodegenerative disease (2020) (18)
Nanosecond Laser Treatment for Age-Related Macular Degeneration Does Not Induce Focal Vision Loss or New Vessel Growth in the Retina. (2018) (18)
Microperimetry for geographic atrophy secondary to age-related macular degeneration. (2019) (18)
Effects of simvastatin on retinal structure and function of a high-fat atherogenic mouse model of thickened Bruch's membrane. (2014) (17)
Survival Bias When Assessing Risk Factors for Age-Related Macular Degeneration: A Tutorial with Application to the Exposure of Smoking (2017) (16)
OCT Signs of Early Atrophy in Age-Related Macular Degeneration: Interreader Agreement (16)
Plasma levels of amyloid beta and other proinflammatory mediators in patients with age-related macular degeneration (2015) (16)
Interpretation of Subretinal Fluid Using OCT in Intermediate Age-Related Macular Degeneration. (2018) (16)
Ranibizumab therapy for choroidal neovascularization secondary to non‐age‐related macular degeneration causes (2012) (15)
Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM study (2008) (15)
Best's macular dystrophy in Australia: phenotypic profile and identification of novel BEST1 mutations (2011) (15)
Repeatability of Retinal Sensitivity Measurements Using a Medmont Dark-Adapted Chromatic Perimeter in Healthy and Age-Related Macular Degeneration Cases (2018) (15)
Adaptation Mechanisms, Eccentricity Profiles, and Clinical Implementation of Red-on-White Perimetry (2008) (15)
Intravitreal therapy in bilateral neovascular age-related macular degeneration. (2014) (15)
Predicting Progression of Age-Related Macular Degeneration Using Optical Coherence Tomography and Fundus Photography. (2020) (15)
Gene-environment interactions and aging visual function: a classical twin study. (2009) (15)
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data (2014) (15)
Topographic Rod Recovery Profiles after a Prolonged Dark Adaptation in Subjects with Reticular Pseudodrusen. (2018) (14)
Charles Bonnet Syndrome in Advanced Retinitis Pigmentosa. (2015) (14)
Assessing residual visual function in severe vision loss. (2014) (14)
Generating mouse models of retinal disease using ENU mutagenesis (2002) (13)
Effect of simvastatin on retinal vascular caliber: the Age‐Related Maculopathy Statin Study (2013) (13)
Retinal vascular caliber and macular telangiectasia type 2. (2009) (13)
Transcriptomic and proteomic retinal pigment epithelium signatures of age-related macular degeneration (2021) (13)
Nitration of tyrosines in complement factor H domains alters its immunological activity and mediates a pathogenic role in age related macular degeneration (2017) (13)
Home Monitoring of Retinal Sensitivity on a Tablet Device in Intermediate Age-Related Macular Degeneration (2018) (13)
Retinal venular caliber predicts visual outcome after intravitreal ranibizumab injection treatments for neovascular AMD. (2012) (12)
Properties of the Impact of Vision Impairment and Night Vision Questionnaires Among People With Intermediate Age-Related Macular Degeneration (2019) (12)
Monoclonal antibody to ICAM-1 prolongs murine heterotopic corneal allograft survival. (1991) (12)
A Tablet-Based Retinal Function Test in Neovascular Age-Related Macular Degeneration Eyes and At-Risk Fellow Eye (2018) (12)
A review of drug options in age-related macular degeneration therapy and potential new agents (2006) (12)
Cost-effectiveness of smoking cessation to prevent age-related macular degeneration (2008) (12)
Age Related Macular Degeneration and Total Hip Replacement Due to Osteoarthritis or Fracture: Melbourne Collaborative Cohort Study (2015) (12)
AMD: to supplement or not? (2004) (12)
Analysis of glutathione S-transferase Pi isoform (GSTP1) single-nucleotide polymorphisms and macular telangiectasia type 2 (2010) (12)
Effect of Residual Retinal Fluid on Visual Function in Ranibizumab-Treated Neovascular Age-Related Macular Degeneration: Effect of Retinal Fluid on Vision Outcomes in HARBOR. (2021) (11)
Heritability of the spatial distribution and peak density of macular pigment: a classical twin study (2012) (11)
Association of the del443ins54 at the ARMS2 locus in Indian and Australian cohorts with age-related macular degeneration (2013) (11)
Do Beta 2-Glycoprotein I Disulfide Bonds Protect the Human Retina in the Setting of Age-Related Macular Degeneration? (2015) (11)
Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study (2017) (10)
Is Renal Function Associated with Early Age-Related Macular Degeneration? (2014) (10)
Testing Protocol and Recruitment in the Genes in Myopia Twin Study (2008) (10)
Examining the added value of microperimetry and low luminance deficit for predicting progression in age-related macular degeneration (2020) (10)
Relationship between reticular pseudodrusen and choroidal thickness in intermediate age‐related macular degeneration (2018) (10)
Expectations of a Visual Prosthesis: Perspectives From People With Impaired Vision (2010) (9)
Psychophysics of a suprachoroidal retinal prosthesis (2013) (9)
AGE-RELATED MACULAR DEGENERATION PHENOTYPES ASSOCIATED WITH MUTUALLY EXCLUSIVE HOMOZYGOUS RISK VARIANTS IN CFH AND HTRA1 GENES (2015) (9)
Optical coherence tomography-guided retinal prosthesis design: model of degenerated retinal curvature and thickness for patient-specific devices. (2014) (9)
Geographic Atrophy Trials: Turning the Ship around May Not Be That Easy. (2018) (9)
Gaming to improve vision: 21st century self‐monitoring for patients with age‐related macular degeneration (2018) (9)
New Technologies to Study Functional Genomics of Age-Related Macular Degeneration (2021) (9)
Retinal venular calibre dilatation after intravitreal ranibizumab treatment for neovascular age‐related macular degeneration (2012) (9)
Urocanic acid in allotransplantation. (1990) (9)
Grand Challenges in global eye health: a global prioritisation process using Delphi method (2022) (9)
Dual roles of different redox forms of complement factor H in protecting against age related macular degeneration (2018) (8)
Association Study of Mannose-Binding Lectin Levels and Genetic Variants in Lectin Pathway Proteins with Susceptibility to Age-Related Macular Degeneration: A Case-Control Study (2015) (8)
Performance of a Defect-Mapping Microperimetry Approach for Characterizing Progressive Changes in Deep Scotomas (2019) (8)
Mirror-image congenital esotropia in monozygotic twins. (2006) (8)
New Treatment Modalities for Geographic Atrophy (2017) (8)
Intercellular adhesion molecule (ICAM‐1) inhibition can induce tolerance in vivo (1991) (8)
Intravitreous injections (2006) (8)
Disparities in access to anti‐vascular endothelial growth factor treatment for neovascular age‐related macular degeneration (2017) (7)
Age-related macular degeneration and mortality: the Melbourne Collaborative Cohort Study (2017) (7)
Deficits in Monocyte Function in Age Related Macular Degeneration: A Novel Systemic Change Associated With the Disease (2021) (7)
TENAYA and LUCERNE (2021) (7)
Validation of an Automated Quantification of Relative Ellipsoid Zone Reflectivity on Spectral Domain-Optical Coherence Tomography Images (2020) (7)
Analysis of the Y 402 H Variant of the Complement Factor H Gene in Age-Related Macular Degeneration (2006) (7)
Imaging Lenticular Autofluorescence in Older Subjects (2017) (7)
Retinal vascular changes following intravitreal ranibizumab injections for neovascular AMD over a 1-year period (2012) (7)
The 5 min meta-analysis: understanding how to read and interpret a forest plot (2022) (7)
Chapter 59 – Age Changes in Bruch's Membrane and Related Structures (2006) (7)
Age-Related Macular Degeneration in Ethnically Diverse Australia: Melbourne Collaborative Cohort Study (2015) (7)
Analysis of the RDS/peripherin gene in age‐related macular degeneration (2007) (7)
Visual Acuity Response Profiles in Patients With Neovascular Age-related Macular Degeneration Treated Quarterly With Ranibizumab in the EXCITE Trial (2009) (6)
Reticular Pseudodrusen on the Risk of Progression in Intermediate Age-Related Macular Degeneration. (2022) (6)
Subthreshold Nanosecond Laser in Age-Related Macular Degeneration: Observational Extension Study to the LEAD Clinical Trial. (2021) (6)
Cuticular Drusen in Age-Related Macular Degeneration: Association with Progression and Impact on Visual Sensitivity. (2022) (6)
Clinical audit as an educative tool for optometrists: an intervention study in age‐related macular degeneration (2020) (6)
Refractive Errors in Twin Studies (2006) (6)
The clinician’s guide to interpreting a regression analysis (2022) (6)
Optical Coherence Tomography Signs of Early Atrophy in Age-related Macular Degeneration: Inter-Reader Agreement. CAM Report 6. (2021) (6)
Age-related macular degeneration and mortality: the Melbourne Collaborative Cohort Study. (2017) (6)
Does aspirin increase the risk of age-related macular degeneration? (2014) (6)
Role of Genetic Factors in Lower- and Higher-Order Aberrations – The Genes in Myopia Twin Study (2009) (6)
Human Pluripotent Stem Cell Strategies for Age-Related Macular Degeneration (2014) (6)
Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration. (2020) (6)
Choroidal lesions preceding symptom onset in birdshot chorioretinopathy. (2006) (6)
Impact of Residual Subretinal Fluid Volumes on Treatment Outcomes in a SRF-tolerant Treat & Extend Regimen. (2021) (6)
Presymptomatic Retinal Sensitivity Changes in Intermediate Age-Related Macular Degeneration Associated With New Retinal Fluid (2019) (6)
Rasch Analysis of the Independent Mobility Questionnaire (2016) (6)
Can the Onset of Atrophic Age-Related Macular Degeneration Be an Acceptable Endpoint for Preventative Trials? (2020) (6)
UV-B irradiation of donor skin and cornea prior to allotransplantation in mice. (1989) (6)
Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy (iRORA) in Age-related Macular Degeneration: CAM Report 4 (2020) (6)
A comparison of methods to estimate the survivor average causal effect in the presence of missing data: a simulation study (2019) (6)
Enhancing object contrast using augmented depth improves mobility in patients implanted with a retinal prosthesis (2015) (5)
Age-related macular degeneration: what's new and on the horizon. (2014) (5)
Clinical and social characteristics associated with reduced visual acuity at presentation in Australian patients with neovascular age‐related macular degeneration: a prospective study from a long‐term observational data set. The Fight Retinal Blindness! Project (2018) (5)
Relationship between reticular pseudodrusen and choroidal thickness in intermediate age‐related macular degeneration: response (2018) (5)
Phase 2b Study of Brimonidine DDS: Potential Novel Treatment for Geographic Atrophy (2019) (5)
Splitting the Lumps: The Importance of Phenotyping Drusen. (2018) (5)
Image processing for visual prostheses: A clinical perspective (2013) (5)
The genetics of age‐related macular degeneration (2001) (5)
Immunosuppression using a monoclonal antibody to ICAM-1 in murine allotransplantation. (1992) (5)
Subthreshold Nano-Second Laser Treatment and Age-Related Macular Degeneration (2021) (5)
Bionic Vision Australia - Implantation of a suprachoroidal retinal prosthesis-results for the first participants (2013) (5)
Prophylactic laser in age-related macular degeneration: the past, the present and the future (2018) (5)
Natural History of Quantitative Autofluorescence in Intermediate Age-Related Macular Degeneration. (2020) (5)
To dry or not too dry: should we be more tolerant of stable subretinal fluid in patients receiving anti‐vascular endothelial growth factor treatment for neovascular age‐related macular degeneration? (2015) (5)
Seven-year Trends in Visual Acuity at First Presentation in Patients with Neovascular AMD. (2017) (5)
Managing neovascular age‐related macular degeneration: a step into the light (2007) (5)
Antivascular endothelial growth factor treatments for neovascular age‐related macular degeneration save sight, but does everyone get treated? (2013) (4)
New approaches to the treatment of Age-Related Macular Degeneration (AMD). (2022) (4)
Hyporeflective Cores within Drusen: Association with Progression of Age-Related Macular Degeneration and Impact on Visual Sensitivity. (2021) (4)
POLYMORPHISMS IN THE APOE GENE AND THE LOCATION OF RETINAL FLUID IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (2014) (4)
Marked discordance for myopia in female monozygotic twins (2006) (4)
Baseline characteristics and age-related macular degeneration in participants of the “ASPirin in Reducing Events in the Elderly” (ASPREE)-AMD trial (2020) (4)
Safety and Efficacy of Quarterly vs. Monthly Ranibizumab Injections in Patients With Neovascular Age-related Macular Degeneration: 12-months Results of the EXCITE Study (2009) (4)
Lessons learnt inform our approach to new antivascular endothelial growth factor treatments for neovascular age‐related macular degeneration (2013) (4)
Wound leak after intravitreal injection of bevacizumab. (2008) (4)
Almost total protection from age-related macular degeneration by haplotypes of the Regulators of Complement Activation. (2011) (4)
A clinician’s guide to network meta-analysis (2022) (4)
Binding of Gtf2i-β/δ transcription factors to the ARMS2 gene leads to increased circulating HTRA1 in AMD patients and in vitro (2021) (4)
Relationship Between Rod-Mediated Sensitivity, Low-Luminance Visual Acuity, and Night Vision Questionnaire in Age-Related Macular Degeneration (2020) (4)
Treatment of age‐related macular degeneration (2005) (3)
Association Studies of the Alleles of the Apolipoprotein (ApoE) Gene and Age Related Macular Degeneration (AMD) (2002) (3)
A model of the corneal allograft reaction. (1990) (3)
Can HMG Co–A Reductase Inhibitors (Statins) Slow the Progression of AMD? (2005) (3)
Deep Learning Applied to Automated Segmentation of Geographic Atrophy in Fundus Autofluorescence Images (2021) (3)
Identification of a mutation in the PKD2 gene in a family with age‐related macular degeneration (2004) (3)
Lifestyle and age-related macular degeneration (2009) (3)
Baseline characteristics and 1-year outcomes of patients with neovascular age-related macular degeneration from the real-world LUMINOUS™ study: global results vs Australian cohort (2016) (3)
Association between Patient-Reported Outcomes and Time to Late Age-Related Macular Degeneration in the Laser Intervention in Early Stages of Age-Related Macular Degeneration Study. (2020) (3)
Investigating the discrepancy between MAIA and MP‐1 microperimetry results (2021) (3)
Exploring Reticular Pseudodrusen Extent and Impact on Mesopic Visual Sensitivity in Intermediate Age-Related Macular Degeneration (2022) (3)
The short-term compliance and concordance to in clinic testing for tablet-based home monitoring in age-related macular degeneration. (2021) (3)
Comparison of Visual Function Tests in Intermediate Age-Related Macular Degeneration (2021) (3)
Psychosocial assessment of potential retinal prosthesis trial participants (2019) (3)
review and meta-analysis age related macular degeneration: systematic Dietary antioxidants and primary prevention of (2007) (3)
Sensitivity analysis in clinical trials: three criteria for a valid sensitivity analysis (2022) (2)
Author reply: To PMID 25109931. (2015) (2)
Sorsby's Fundus Dystrophy: a case report to raise awareness of the disease and potential future treatments (2009) (2)
Automatic segmentation of nine layer boundaries in OCT images using convolutional neural networks and graph search (2017) (2)
A prototype suprachoroidal retinal prosthesis: device reliability and patient safety report of a 2 year clinical study (2015) (2)
When to believe a subgroup analysis: revisiting the 11 criteria (2022) (2)
Effect of subthreshold nanosecond laser on retinal structure and function in intermediate age‐related macular degeneration (2021) (2)
Younger siblings, C-reactive protein, and risk of age-related macular degeneration. (2013) (2)
Using Microperimetry and Low Luminance Visual Acuity to Detect the Onset of Late Age-Related Macular Degeneration: A LEAD Study Report. (2020) (2)
Exploring the contribution of ARMS2 and HTRA1 genetic risk factors in age-related macular degeneration (2022) (2)
Discordant Unilateral Myopia in Adult Female Monozygotic Twins (2007) (2)
Natural history of the relative ellipsoid zone reflectivity in age-related macular degeneration. (2022) (2)
Australian Angiogram Review Panel – monitoring the use of photodynamic therapy with verteporfin (2006) (2)
The dot-and-fleck retinopathy of X linked Alport syndrome is independent of complement factor H (CFH) gene polymorphisms (2008) (2)
A deep learning model for automated segmentation of geographic atrophy imaged with swept-source optical coherence tomography images. (2022) (2)
Neovascular age‐related macular degeneration at treatment intervals of 14 weeks or greater (2021) (2)
Hydroxychloroquine retinopathy: screening needed to prevent blindness (2010) (2)
Gene Variants in the HTRA1 and ARMS2 genes and Outcome of Anti-VEGF Treatment in Neovascular AMD (2012) (2)
COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A 'TREAT AND EXTEND' PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12-MONTH INTERIM ANALYSIS OF THE RIVAL STUDY (2017) (2)
Cardiovascular Adverse Effects of Phenylephrine Eyedrops (2015) (2)
Focus on Survival Analysis for Eye Research (2021) (2)
Effect of chronic electrical stimulation with a fully implantable electrode on photoreceptor survival in a retinal degeneration model (2019) (2)
A Deep Learning Framework for the Detection and Quantification of Reticular Pseudodrusen and Drusen on Optical Coherence Tomography (2022) (1)
Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy: Longitudinal Evaluation in Age-Related Macular Degeneration. (2022) (1)
Nascent Geographic Atrophy as a Surrogate Endpoint in Age-Related Macular Degeneration (2019) (1)
Slowing Progression of Age-Related Macular Degeneration With Statins: A Randomised, Controlled Clinical Trial (2003) (1)
The Associations of Dietary Lutein, Zeaxanthin and Fats With Age–Related Macular Degeneration: The Melbourne Collaborative Cohort Study (2006) (1)
2006 Council Lecture: Lancelot to the rescue: realizing the promise of genomic medicine (2007) (1)
Novel Nanosecond Laser Treatment to Prevent Vision Loss From Age-Related Macular Degeneration (2010) (1)
Is AMD Equally Prevalent in Australians of Southern-European and Anglo-Celtic Origin ? (2010) (1)
Retina Fundus Autofluorescence Characteristics of Nascent Geographic Atrophy in Age-Related Macular Degeneration (2015) (1)
Drug treatment of macular degeneration (2002) (1)
Decrease in Electrode-Retina Distance over Time and its Effect on Electrical Impedances in a Suprachoroidal Retinal Prosthesis (2013) (1)
Age-Related Macular Degeneration: Not So Wet and Dry. (2020) (1)
Is There a Case for Case-Control Studies in the Exploration of Retrospective Data Sets? (2021) (1)
A prototype suprachoroidal retinal prosthesis enables improvement in a tabletop object detection task (2015) (1)
Foreword: Age-related macular degeneration (2014) (1)
Treatment to fellow eyes of unilateral retinal pigment epithelial tears with prophylactic laser (1996) (1)
Choroidal Thickness in Retinitis Pigmentosa (2011) (1)
Treating Neovascular Age-Related Macular Degeneration-So Much More to Learn. (2020) (1)
P2X7-mediated alteration of membrane fluidity is associated with the late stages of age-related macular degeneration (2022) (1)
Dietary Fat and Fish Consumption and its Association with Age-related Macular Degeneration (2006) (1)
Guidelines for patient management: considerations before adoption into practice (2022) (1)
A clinical perspective on the expanding role of artificial intelligence in age-related macular degeneration (2022) (1)
PERIPHERAL RETINAL DRUSEN-LIKE DEPOSITS IN GUCY2C CONGENITAL SECRETORY DIARRHEA SYNDROME. (2018) (1)
Dose Response in the Subthreshold Nanosecond Laser Trial in Early Stages of AMD: A LEAD Study Report. (2021) (1)
Impact of Reticular Pseudodrusen on Choriocapillaris Flow Deficits and Choroidal Structure on Optical Coherence Tomography Angiography (2022) (1)
New treatments for age-related macular degeneration (2007) (1)
Model Structure Uncertainty in the Characterization and Growth of Geographic Atrophy (2021) (1)
Sub-Threshold Nanosecond Laser Intervention in Age-Related Macular Degeneration : The LEAD Randomized Controlled Clinical Trial (2018) (1)
Content validity of the NEI VFQ-25 in patients with geographic atrophy (2017) (1)
Twelve-Month Outcomes of "Treat and Extend" aflibercept Therapy for Neovascular Age-Related Macular Degeneration (2016) (1)
Abdominal Obesity - Not BMI - Increases Risk of Late AMD in Men (2010) (1)
Concordant bilateral Duane’s Retraction Syndrome (type 1) in female monozygotic twins (2006) (1)
Genetic pleiotropy between age-related macular degeneration and 16 complex diseases and traits (2017) (1)
Genes and Age-Related Macular Degeneration (2005) (1)
Treatment and Prevention of Age‐Related Macular Degeneration (2004) (1)
Multiallelic copy number variation in the complement component 4A (C4A) gene is associated with late-stage age-related macular degeneration (AMD) (2016) (1)
The Prevalence Of Residual Visual Field Islands In Retinitis Pigmentosa (2013) (1)
An Epigenetic Study of Monozygotic Twin Pairs Discordant for Birth-Weight (2011) (1)
Alleles of the Y402H Variant of the Complement Factor H (CFH) Gene and Progression of Age Related Macular Degeneration (AMD) (2007) (1)
How Blind Is A Flat ERG? - An Improved Method Of Assessing Retinal Function In Patients With Extremely Poor Vision (2012) (1)
The clinician’s guide to randomized trials: interpretation (2022) (1)
BASELINE CHARACTERISTICS OF THE FLUID STUDY PATIENTS: A RANDOMISED CLINICAL TRIAL INVESTIGATING THE NEED FOR COMPLETE RESOLUTION OF SUB-RETINAL FLUID (SRF) IN RANIBIZUMAB-TREATED PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) USING A TREAT AND EXTEND (T&E) REGIMEN (2015) (1)
Real Time Motion Recovery using a Hemispherical Sensor (2008) (1)
The importance of multidisciplinary collaborations in the future of bionic vision (2013) (1)
Retina Comparison Between Multifocal Electroretinography and Microperimetry in Age-Related Macular Degeneration (2014) (1)
Cohort studies investigating the effects of exposures: key principles that impact the credibility of the results (2022) (1)
Performance of a Smart Device over 12-Months for Home Monitoring of Patients with Intermediate Age-Related Macular Degeneration (2023) (1)
Correction to: The clinician’s guide to p values, confidence intervals, and magnitude of effects (2022) (1)
Response to ‘Balancing the risks and benefits in AMD’ (2005) (0)
Prevalence and Progression of Retinal Pigment Epithelium and Outer Retinal Atrophy in Patients With Neovascular Age-Related Macular Degeneration in the Fellow Eye (2018) (0)
Whole Exome sequencing to identify the pharmacogenetic basis of retinal fluid clearance in anti-VEGF treated AMD (2017) (0)
Multiple phagocytosis related factors underpin the pathogenesis of age-related macular degeneration (2019) (0)
Retina Longitudinal Assessment of Rod Function in Intermediate Age-Related Macular Degeneration With and Without Reticular (2019) (0)
Identification of a Novel Variant Associated with anti-VEGF Response in Age-related Macular Degeneration Using Exome Chip Analysis (2017) (0)
Ethnic disparity in prevalence of retinal vein occlusions amongst older Australians - the Melbourne Collaborative Cohort Study (2013) (0)
Anti-vascular endothelial growth factor therapy and retinal non-perfusion in diabetic retinopathy: A meta-analysis of randomised trials. (2023) (0)
Can Systemic Markers Of Inflammation Predict Subtypes Of Age Related Macular Degeneration (2011) (0)
The Relation of Arterial Structure and Function to the Progression of AMD: the CHARM Study (2004) (0)
Age-related macular degeneration displays shortened telomere length indicating differential biological aging (2016) (0)
Current Issues in Age-Related Macular Degeneration (2014) (0)
Social and clinical characteristics associated with low visual acuity at presentation of AMD (2017) (0)
The Longitudinal Impact of Macular Telangiectasia (MacTel) Type II on Vision-Related Quality of Life: The MacTel Study (2010) (0)
Poster Abstracts (2016) (0)
Assessment Of Interaction Between Smoking And The LOC387715 (ARMS2)/HTRA1 Genes In Risk Of Age-related Macular Degeneration (AMD) (2012) (0)
Monitoring Progression of AMD Through Visual Function Loss (2010) (0)
Automated quantification of retinal fluid and its impact on treatment outcomes in the FLUID study (2020) (0)
Apolipoprotein gene is associated with progression of age-related macular degeneration (2007) (0)
Predictors of Treatment Outcomes With Anti-Vascular Endothelial Growth Factor in Neovascular Age-Related Macular Degeneration (2009) (0)
OPTIMISING ELECTRICAL STIMULATION PARAMETERS FOR A BIONIC EYE (2010) (0)
Contribution Apolipoprotein E Gene Associations in Age-related Macular Degeneration The Melbourne Collaborative Cohort Study (2012) (0)
Anti-vascular Endothelial Growth Factor (VEGF) Treatment in Neovascular Age-Related Macular Degeneration: Outcomes and Outcome Predictors (2016) (0)
COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) USING A TREAT-AND-EXTEND REGIMEN: RESULTS OF THE 24-MONTH SECONDARY EFFICACY OUTCOMES FROM THE RIVAL STUDY, A RANDOMIZED CLINICAL TRIAL (2018) (0)
Self-rated eyesight among healthy older Australians: Baseline results of the ASPREE Longitudinal Study of Older Persons. (2023) (0)
Alleles of the Apolipoprotein (ApoE) gene and progression of age related macular degeneration (AMD) (2004) (0)
The Apolipoprotein (ApoE) Gene Is a Risk Factor for Age Related Macular Degeneration (AMD) (2003) (0)
Continuing Medical Education: Age-related macular degeneration and mortality: the Melbourne Collaborative Cohort Study (2017) (0)
A transcriptome-wide association study based on 27 tissues identifies 106 genes potentially relevant for disease pathology in age-related macular degeneration (2020) (0)
Retina Quantitative Analysis of the Ellipsoid Zone Intensity in Phenotypic Variations of Intermediate Age-Related Macular Degeneration (2017) (0)
Verteporfin of its Use in the Management of Subfoveal Choroidal Neovascularisation (2006) (0)
Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next? (2022) (0)
Longitudinal Changes in Microperimetric Retinal Sensitivity in Intermediate Age-Related Macular Degeneration (2014) (0)
Role of anti-vascular endothelial growth factor in the management of non-proliferative diabetic retinopathy without centre-involving diabetic macular oedema: a meta-analysis of trials. (2022) (0)
Microglial response to nanosecond laser application to the retinal pigment epithelium (2013) (0)
Reticular pseudodrusen drives the loss of scotopic function in intermediate age-related macular degeneration (2017) (0)
Corneal Endothelial Cell Density in Patients With Neovascular Age-related Macular Degeneration Treated With Ranibizumab in the EXCITE Study (2009) (0)
Assessment Of Structural And Genetic Variation At The Complement Factor H Related 1-5 Gene Cluster In Age Related Macular Degeneration (AMD) (2011) (0)
Bionic Eyes: Vision Restoration Through Electronic or Photovoltaic Stimulation (2014) (0)
Retina Assessment of Retinotopic Rod Photoreceptor Function Using a Dark-Adapted Chromatic Perimeter in Intermediate Age-Related Macular Degeneration (2016) (0)
Seeing the patient’s perspective: a guide to patient-reported outcome measures and minimal important differences in ophthalmic research (2022) (0)
A Risk Scoring System for Age-related Macular Degeneration Incorporating Genetic Susceptibility and Environmental Exposures (2011) (0)
Fluorescin angiographic changes following prophylactic macular coagulation for high risk age-related maculopathy (1999) (0)
Interaction of Inflammatory and Genetic Risks for Prevalent AMD and AMD Progression (2009) (0)
Retina Longitudinal Associations Between Microstructural Changes and Microperimetry in the Early Stages of Age-Related Macular Degeneration (2016) (0)
The Role of Aspirin in Age-related Macular Degeneration: the ASPREE-AMD Randomized Controlled Trial (2018) (0)
Multi‐focal electro‐retinogram response following sub‐threshold nano‐second laser intervention in age‐related macular degeneration (2020) (0)
The Effect of Statins on hsCRP and Cholesterol Levels in Subjects With High Risk Early AMD - The ARMSS Study (2010) (0)
Treatment of age related macular degeneration using nanosecond laser therapy: Safety profile studies in humans and mice (2018) (0)
Treat and extend- A successful approach to decrease the number of intravitreal anti-VEGF injections in neovascular age-related macular degeneration without compromising the efficacy (2013) (0)
Retinal Functional Improvement With Nano-laser Treatment In High Risk Early Age-related Macular Degeneration (2011) (0)
Retinal Curvature Variations of Retinitis Pigmentosa Subjects (2012) (0)
Müller Cells in Macular Pathology (2010) (0)
Genetics of reticular pseudodrusen in age-related macular degeneration. (2022) (0)
Age-Related Macular Degeneration: Who Progresses to Vision-Threatening Disease? Learning to See More in the Image. (2021) (0)
The Impact Of Anti-vegf Treatment On Vision-related Quality Of Life In Age-related Macular Degeneration Outside Clinical Trials (2012) (0)
Re: Wu et al.: Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration (Ophthalmology 2014;121:2415-22) Reply (2015) (0)
Assessment and monitoring of retinal function in age-related macular degeneration (2014) (0)
Long-term compliance to weekly home-monitoring of vision with a tablet perimeter in patients with age-related macular degeneration (2019) (0)
Loss of P2X7 receptor function increases the risk of age related macular degeneration: Investigation of human genetics and mouse models (2016) (0)
Retina Microperimetry of Nascent Geographic Atrophy in Age-Related Macular Degeneration (2014) (0)
Microperimetry and Multifocal Electroretinography in Reticular Pseudodrusen and Intermediate Age-Related Macular Degeneration (2015) (0)
Optimizing treat and extend regimens using artifical intelligence based on OCT imaging in the FLUID study (2019) (0)
The Prevalence of Idiopathic Macular Telangiectasia Type 2 (IMT): The Melbourne Collaborative Cohort Study (2009) (0)
Static and Flicker perimetry as a functional marker in Age-related Macular Degeneration (2012) (0)
BALATON and COMINO: Phase 3 Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion: Study Design and Rationale (2023) (0)
Reply. (2022) (0)
Heritability of Clinical Features of Age–Related Macular Degeneration – A Twin Study (2005) (0)
Pooled GWAS identifies a novel gene: OR52B4 influencing anti-VEGF treatment response in Age related macular degeneration (2016) (0)
INDUCING DRUSEN REDUCTION IN THE EARLY STAGES OF AGE-RELATED MACULAR DEGENERATION (AMD): GOOD, BAD OR INDIFFERENT? (2014) (0)
Are glutathione S-Transferase Pi isoform (GSTP1) single nucleotide polymorphisms (SNPs) associated with type 2 idiopathic macular telangiectasia? (2010) (0)
Toward an Animal Model of AMD: Functional Losses Induced by High Cholesterol Diets (2005) (0)
Visual Function Separates Out Different Amd Subgroups (2006) (0)
Bilateral Multifocal Electroretinogram Changes After Nanosecond Laser In Subjects With Early Age-related Macular Degeneration (2012) (0)
Treating Geographic Atrophy-Are We Ready? A Call to Image. (2022) (0)
Association between exposure to Chlamydia pneumoniae infection and AMD progression: Cardiovascular Health and Age–Related Maculopathy (CHARM) Study (2004) (0)
AUDIT ON ANTI-VEGF TREATMENT FOR NEOVASCULAR AMD AT THE ROYAL VICTORIAN EYE AND EAR HOSPITAL (RVEEH) (2011) (0)
Reply (2002) (0)
Treatment with a nanosecond laser reduces drusen and thins Bruch's membrane: evidence from human and animal model studies (2014) (0)
SUB-RETINAL FLUID IN INTERMEDIATE AMD - CASES OF NON-EXUDATIVE DETACHMENT OF THE NEUROSENSORY RETINA (2015) (0)
Doyne's Phenotype in the Absence of the Arg345trp Mutation of the Efemp1 Gene (2003) (0)
Cost Effectiveness and Resource Allocation Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration (2008) (0)
ALTERED PERIPHERAL MONOCYTE INNATE PHAGOCYTOSIS IN ALZHEIMER’S DISEASE (2016) (0)
VISION LOSS AND QUALITATIVE OCT APPEARANCE IN EYES WITH NEOVASCULAR AMD TREATED WITH ANTI-VEGF DRUGS (2013) (0)
APOE Gene-environment Interaction In AMD Risk (2011) (0)
Lutein, Zeaxanthin and n-3 Fatty Acids: Are they Subjected to a Systemic Bias in Research on Nutrition and Age-related Macular Degeneration? (2006) (0)
Fundus Autoﬂuorescence Characteristics of Nascent Geographic Atrophy in Age-Related Macular Degeneration (2015) (0)
De novo choroidal osteoma after laser photocoagulation of a peripapillary choroidal neovascular membrane (2023) (0)
Contribution Younger Siblings , C-Reactive Protein , and Risk of Age-Related Macular Degeneration (2013) (0)
Human Serum Metabolomics Study in Macular Telangiectasia Type 2 (2018) (0)
Edinburgh Research Explorer Evidence of association of APOE with age-related macular degeneration (2018) (0)
THE ROLE OF REDUCED PHAGOCYTOSIS IN THE PATHOGENESIS OF AGE-RELATED MACULAR DEGENERATION (2016) (0)
Abnormal Macular Function in Macular Telangiectasia (2007) (0)
Interpreting results from randomized controlled trials: What measures to focus on in clinical practice. (2023) (0)
Identifying the Genetic Components to Myopia – A Classical Twin Study (2006) (0)
Visual outcomes of an Inject and Extend protocol of intravitreal anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration over two years (2013) (0)
Data-Driven Pattern Analysis of Dietary Items in Relation to Age-Related Macular Degeneration (2013) (0)
Topographic rod functional recovery profiles after prolonged dark-adaptation in eyes with reticular pseudodrusen (2018) (0)
Knockout of AMD-associated gene POLDIP2 reduces mitochondrial superoxide in human retinal pigment epithelial cells (2022) (0)
The Role of Carotenoids and Fats in the Progression of Age–Related Macular Degeneration (2006) (0)
Sunday 20 November (2016) (0)
Deep survival modeling of longitudinal retinalOCT volumes for predicting the onset of atrophyin patients with intermediate AMD (2023) (0)
Hyperpigmentary abnormalities in age-related macular degeneration: association with progression and impact on visual sensitivity. (2022) (0)
Detecting subclinical abnormal choroidal vascular complexes using spectral domain optical coherence tomography in intermediate age-related macular degeneration. (2019) (0)
Re: Guymer et al.: Subthreshold nanosecond laser intervention in age-related macular degeneration: The LEAD Randomized Controlled Clinical Trial (Ophthalmology. 2019;126:829-838) Reply (2019) (0)
The local and systemic effects following subthreshold nanosecond laser treatment to the posterior retina (2019) (0)
Association of Genetic VariantsWith Response to Anti – Vascular Endothelial Growth Factor Therapy in Age-RelatedMacular Degeneration (2018) (0)
Do VEGF Gene Variants Contribute To The Treatment Outcomes Of Intravitreal Anti-VEGF Treatment In Patients With Neovascular Age-related Macular Degeneration? (2011) (0)
Identifying Genetic Components of Visual Function - A Classical Twin Study (2007) (0)
Sunday 21st November (2010) (0)
Title Nitration of tyrosines in complement factor H domains alters its immunological activity and mediates a pathogenic role in age related macular degeneration (2017) (0)
Passive safety outcomes of a preclinical 44-channel suprachoroidal retinal prosthesis (2017) (0)
A model of 10-year outcomes of anti-VEGF treatment for neovascular age-related macular degeneration (2014) (0)
Age-related macular degeneration (2023) (0)
Monday 4th November (2013) (0)
Qualitative Appearance of OCT Predicts Visual Outcome at 12 months Following Anti-VEGF Therapy for Neovascular AMD (2011) (0)
Noninferiority randomised trials in ophthalmology. (2023) (0)
Orientation and mobility considerations in bionic eye research (2012) (0)
Optimizing cost-effectiveness analyses of treatments for neovascular age-related macular degeneration using real-life data (2013) (0)
Implications of Analysis Unit on Epidemiology of Multimodal Imaging-Defined Reticular Pseudodrusen: When 2 Eyes Are Better Than 1. (2020) (0)
TOLERATING A DEGREE OF SUBRETINAL FLUID IN THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) WITH RANIBIZUMAB USING A TREAT AND EXTEND REGIMEN: 24 MONTH RESULTS FROM THE PHASE IV, RANDOMISED, SINGLE-MASKED, MULTI-CENTRE FLUID STUDY (2018) (0)
Identification of independent associations involving HLA Class II loci and Age-Related Macular Degeneration (AMD) (2014) (0)
HMG Co-A Reductase Inhibitor Delays Progression Of Early AMD. The Age-Related Maculopathy Statin Study(ARMSS) (2011) (0)
Reduction of the OCT second hyper-reflective band intensity is associated with a decreased in retinal function in eyes with age-related macular degeneration (2013) (0)
CHAPTER 7 – Genetics of retinal disease (2010) (0)
Reply. (2019) (0)
Assessment of Copy Number Variation in Genes Associated with in Age related Macular Degeneration (AMD) (2012) (0)
The Surgical Approach and Clinical Assessment of Chronic Implantation of a Wide-Field Suprachoroidal Array in a Feline Model (2011) (0)
Qualitative OCT Appearance and Vision Change in Eyes with Neovascular AMD Treated with Anti-VEGF Drugs (2014) (0)
Randomized Phase 2b Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-related Macular Degeneration. (2023) (0)
Reduced Phagocytosis as a novel pathogenic mechanism in AMD pathogenesis (2017) (0)
Single Nucleotide Polymorphism (SNP) Analysis of the Complement C3 Gene and Age Related Macular Degeneration (AMD) (2008) (0)
Effects of Switching from Ranibizumab to Aflibercept on Visual Outcome, Lesion Activity and Treatment Intensity in Eyes with Neovascular Age-Related Macular Degeneration (2015) (0)
Randomized Phase 2b Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-related Macular Degeneration. (2023) (0)
Systematic Reviews and Meta- and Pooled Analyses Variations in Apolipoprotein E FrequencyWith Age in a Pooled Analysis of a Large Group of Older People (2011) (0)
The reliability of rod and cone sensitivity measurements using a novel dark-adapted chromatic perimeter (2016) (0)
Implementation of CRT Technology for Assessment of Dark Adaptation Kinetics in AMD Patients. (2004) (0)
ORIENTATION AND MOBILITY REHABILITATION: CANES, CANINES AND BIONIC EYES (2012) (0)
POLYMORPHISMS OF THE APOE GENE AND THE QUALITATIVE OCT APPEARANCE IN EYES WITH NEOVASCULAR AMD (2012) (0)
Retina Imaging Lenticular Autofluorescence in Older Subjects (2017) (0)
Pluripotent stem cell-based models to investigate retinal pigmented epithelium function and disease (2013) (0)
Epigenetic Regulations in Age-related Macular Degeneration (2011) (0)
Author index (2002) (0)
Complexities in interpreting subretinal fluid on spectral-domain optical coherence tomography in intermediate age-related macular degeneration (2017) (0)
Potential Role Of Flicker Perimetry In Predicting Geographic Atrophy In Age-related Macular Degeneration (2011) (0)
Novel Laser treatment for Early Age-related Macular Degeneration (2013) (0)
A Tag SNP Approach Defines a Minimal Risk Associated Region in the CFH Gene in Individuals With AMD (2010) (0)
Longitudinal Changes inMicroperimetry and Low Luminance Visual Acuity in Age-RelatedMacular Degeneration (2015) (0)
Does Age Modify Associations with Complement Factor H in Age Related Macular Degeneration (2012) (0)
Home-monitoring by age-related macular degeneration patients using a tablet perimeter. (2018) (0)
Contribution Abdominal Obesity and Age-related Macular Degeneration (2011) (0)
Tolerating Subretinal Fluid in the Treatment of Neovascular Age-Related Macular Degeneration With Ranibizumab Using a Treat and Extend Regimen (2018) (0)
Psychosocial Assessment of Potential Retinal Prosthesis Recipients (2018) (0)
Prevalence of Epiretinal Membrane in Older Australians of Southern European or Northern European origin. The Melbourne Collaborative Cohort Study (MCCS) (2011) (0)
Erratum: AMD: To supplement or not? (Clinical and Experimental Ophthalmology (2004) vol. 32 (341-3)) (2004) (0)
Correction to: A comparison of methods to estimate the survivor average causal effect in the presence of missing data: a simulation study (2020) (0)
The retinal pifment epithelium and Bruch's membrane: structure and function (2005) (0)
Preliminary Results of the Bionic Vision Australia Suprachoroidal Visual Prosthesis Pilot Trial (2014) (0)
VEGF levels in serum and the outcome of intravitreal anti-VEGF treatment in neovascular age-related macular degeneration (2014) (0)
The clinician’s guide to p values, confidence intervals, and magnitude of effects (2021) (0)
Multifocal Electroretinogram Responses Following Subthreshold Nanosecond Laser Intervention In Age-Related Macular Degeneration. (2019) (0)
The Influence of Fellow Eye Status on Visual Function in Late AMD (2007) (0)
FIVE OF THE AUTHORS REPLY (2009) (0)
Long-Term Outcomes of Treatment ofNeovascular Age-Related MacularDegeneration (2015) (0)
Physical Activity and Age-related Macular Degeneration (2015) (0)
Late Age-related macular degeneration is associated with increased mortality (2016) (0)
Retina Subretinal Drusenoid Deposits and the Loss of Rod Function in Intermediate Age-Related Macular Degeneration (2018) (0)
Author reply: To PMID 23021093. (2013) (0)
AntieVascular Endothelial Growth Factor Use and Atrophy in Neovascular Age-Related Macular Degeneration Systematic Literature Review and Expert Opinion (0)
CHRONIC IMPLANTATION OF A SUPRACHOROIDAL ELECTRODE ARRAY IN A FELINE MODEL (2010) (0)
Enhanced Diagnosis of AMD by Comparing Central and Peripheral Dark Adaptation (2006) (0)
HOME MONITORING OF VISION IN THE 21ST CENTURY: IMPROVING OUTCOMES FOR PATIENTS WITH NEOVASCULAR AMD (2016) (0)
Heritability for Known Risk Factors in Myopia - The Genes in Myopia (GEM) Twin Study (2007) (0)

This paper list is powered by the following services:

Other Resources About Robyn Guymer

en.wikipedia.org

What Schools Are Affiliated With Robyn Guymer?

Robyn Guymer is affiliated with the following schools:

Robyn Guymer's Academic­Influence.com Rankings